Paradigm Biopharmaceuticals Ltd.ASX: PAR

iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study

Apr 4, 2023 at 3:50 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment